Thursday, July 18, 2024

TRAIL STOP-LOSS TO 24450

 

TRAIL STOP-LOSS TO 24450

 

WORLD MARKETS

 

On Tuesday, Dow surged 1.8%, notching its best session since June 2023 and hitting fresh record highs. S & P 500 and Nasdaq gained 0.6% and 0.2% respectively. Financials gained after earnings from Bank of America and Morgan Stanley came in ahead of forecasts.  United Health surged 6.5% on the back of better-than-expected second-quarter results.

 

Yesterday, Dow rose 0.6% but S & P 500 and Nasdaq tumbled 1.4% and 2.8% respectively, with the latter posting its worst day since December 2022 as chip-related stocks dropped following reports of more stringent export restrictions from the U.S. and as comments from former U.S. President Donald Trump raised geopolitical tensions.

 

Bloomberg News reported that the Biden administration is considering tougher trade restrictions if companies continue granting China access to U.S.-made technology.

 

Data showed production at U.S. factories increased more than expected in June, contributing to a solid rebound in output in the second quarter.

 

U.S. 10-year treasury yield were flat at 4.159% after falling 7 bps in the previous session. Dollar index tumbled half a percent to 103.74. Gold fell 0.4% to $2458 after climbing 1.9% in the previous session.

 

Brent futures rose $1.34, or 1.6%, to $85.06 a barrel, while WTI crude rose $1.94, or 2.4%, to $82.70.

 

In Europe, FTSE rose 0.3% while DAX and CAC fell 0.4% and 0.1% respectively. Inflation in UK held at 2% on an annual basis in June against forecasts for a 1.9% increase, while the closely watched services inflation came in at 5.7%. Core inflation, however, was in line with expectations.

 

AT HOME

 

After rising three tenth of a percent, benchmark indices cooled off to end higher by 0.1%, extending the winning streak to third straight session and hitting fresh record highs. Sensex settled at 80716, up 51 points while Nifty added 26 points to finish at 24613. Nifty mid-cap index was absolutely flat while small-cap index inched up 0.1%. Nifty Realty and FMCG indices climbed 1.7% and 1% respectively, becoming top gainers among sectoral indices while Media index was the top loser, down 1%, followed by 0.4% lower Healthcare and Pharma indices.

 

FIIs net bought stocks worth Rs 1271 cr but net sold index futures and stock futures worth Rs 58 cr and 3335 cr respectively. DIIs were net sellers to the tune of Rs 529 cr.

 

Rupee appreciated 1 paise to end at 83.58/$.

 

Asian Paints reported weaker-than-expected first quarter with margins hitting multi-quarter low and tough demand conditions resulted in drop in revenue.

 

OUTLOOK

 

Japan’s exports rose 5.4% y-o-y in June, a steep decline from 13.5% in May. Imports grew 3.2%, down from 9.5% in May. Both exports and imports missed expectations of 6.4% and 9.3% growth, respectively. Trade balance reversed from a 1.2 trillion yen deficit in May, or $7.7 billion, to a 224 billion yen surplus.

 

Today morning, Nikkei is down 1.8% while Shanghai and Hang Seng are off 0.5% and 0.1% respectively. GIFT Nifty is suggesting a marginally higher start for our market.

 

In Tuesday's report we had said that 24750-24800 continued to be next target zone for Nifty while 24400-34350 was the immediate support zone, with the stop-loss which, trading longs can be held on to.

 

Nifty, after touching a high of 24661, eased to end at 24613.

 

24750-24800 continues to be next target zone for Nifty; 24450 is the immediate support on the hourly, with the stop-loss which, trading longs could be held on to.

 

For Banknifty, 51749, the low made last week, which roughly coincided with 20-DMA, is the immediate support, upon breach of which, 34-DMA, placed around 51200, would be bigger support to eye. 52800 is the immediate hurdle on hourly chart, upon crossover of which, 53357, the top made last week, would be next upside level to eye.

 

Infosys will report its quarterly earnings today.


Investment in securities market is subject to market risk.

Please check https://www.prudentbroking.com/Disclaimert.aspx for detailed disclaimer. 


No comments:

Post a Comment